Keyphrases
Scotland
100%
Confidence Interval
47%
Vaccine Effectiveness
39%
Scottish
27%
United Kingdom
25%
COVID-19
21%
Influenza
21%
Primary Care
20%
Meta-analysis
18%
Vaccination
16%
Laboratory-confirmed Influenza
15%
Breast Cancer
14%
Healthcare-associated Infections
13%
Hospitalization
12%
Hospital Admission
12%
Lower Urinary Tract Symptoms
11%
Placebo
11%
Breast Cancer Risk
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Human Papillomavirus Vaccine
10%
Risk Factors
9%
COVID-19 Pandemic
9%
Cervical Cancer Screening
9%
National Database
9%
Age Groups
9%
Cancer Mortality
9%
High-risk Human Papillomavirus (HR-HPV)
9%
Influenza-like Illness
8%
Carotid Intima-media Thickness (cIMT)
8%
Seasonal Influenza Vaccine
8%
H1N1
8%
Deprivation
8%
Influenza Vaccine Effectiveness
8%
Record Linkage Study
8%
Hazard Ratio
8%
Influenza Vaccination
7%
Tumor
7%
Randomized Trial
7%
Quality of Life
7%
Population-based
7%
Edinburgh
7%
A(H1N1)pdm09
7%
Vaccination Program
7%
Comorbidity
6%
Seroprevalence
6%
Insulin-like
6%
Growth Factors
6%
Prostate Cancer
6%
Unvaccinated
6%
Test-negative Design
6%
Medicine and Dentistry
COVID-19
38%
Infection
35%
Breast Cancer
29%
Influenza Vaccine
27%
Disease
26%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Cohort Analysis
20%
Primary Health Care
20%
Prevalence
16%
Gene Linkage
15%
Meta-Analysis
15%
Prostate Cancer
13%
Cancer Mortality
13%
Wart Virus
12%
Public Health
11%
Intima-Media Thickness
11%
Maturity Onset Diabetes of the Young
11%
Malignant Neoplasm
10%
COVID-19 Vaccination
10%
Influenza Vaccination
9%
Cohort Effect
9%
Case-Control Study
9%
Asthma
8%
Odds Ratio
8%
Cervical Screening
8%
Healthcare Associated Infection
8%
Cardiovascular System
8%
Hazard Ratio
8%
Placebo
8%
Influenza A Virus (H3N2)
8%
Pandemic Influenza
8%
Wart Virus Vaccine
8%
Serotype
8%
Mortality Rate
8%
Prostate Specific Antigen
7%
Lower Urinary Tract Symptom
7%
Childbirth
7%
Influenza A (H1N1)
7%
Neoplasm
7%
Tamoxifen
7%
Cancer Risk
7%
Seasonal Influenza
7%
COVID-19 Vaccine
7%
Screening
6%
Observational Study
6%
Diabetes
6%
Influenza
6%
Oncology
6%
Hepatitis C
6%
Oral Cancer
6%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
34%
Infection
28%
Disease
26%
Breast Cancer
22%
Prevalence
19%
Influenza Vaccine
17%
Tamoxifen
15%
SARS Coronavirus
14%
Seasonal Influenza
13%
Placebo
13%
Case-Control Study
13%
Cohort Study
11%
Healthcare Associated Infection
11%
Symptom
11%
Biological Marker
10%
Prostate Cancer
9%
Hepatitis C
9%
Lower Urinary Tract Symptom
8%
Pandemic Influenza
8%
Influenza A (H1N1)
8%
Malignant Neoplasm
8%
Prostate Specific Antigen
8%
Non Insulin Dependent Diabetes Mellitus
8%
Neoplasm
7%
Influenza A Virus (H1N1)
7%
COVID-19 Vaccine
7%
Cancer Mortality
7%
Prostate Hypertrophy
7%
Coronavirinae
6%
Asthma
6%
Somatomedin C
6%
Influenza
6%
Carcinoma
6%
Hepatitis C Virus
5%
Fenretinide
5%
Cardiovascular Disease
5%
Ethanol
5%
Human Papillomavirus
5%
Population Study
5%
Antibiotics
5%